跳至主要内容
临床试验/ITMCTR2200006064
ITMCTR2200006064尚未招募1 期

Clinical study of Shenling Baizhu Powder combined with Special Disease Prescription in the treatment of ulcerative colitis with dampness obstruction syndrome of spleen deficiency

Guangdong Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • (1) 18-75 years old, male or female;
  • (2) Meet the diagnostic criteria of ulcerative colitis;
  • (3) Meet the criteria of mild and moderate active stage of ulcerative colitis;
  • (4) Meet the criteria for waiting diagnosis of dampness obstruction syndrome of spleen deficiency;
  • (5) The informed consent is signed.

排除标准

  • (1) Chronic schistosomiasis, bacterial dysentery, intestinal tuberculosis and other infectious colitis, colonic Crohn's disease, radiation enteritis, ischemic enteritis;
  • (2) Patients in lactation, pregnant women and intolerant to this drug;
  • (3) patients with serious primary diseases such as heart, lung, liver, kidney and hematopoietic system, and mental illness;
  • (4) Patients with serious complications such as local stenosis, toxic megacolon, intestinal obstruction, colon cancer, rectal cancer, intestinal perforation and anal diseases;
  • (5) persons with disabilities defined by law (mute, deaf, blind, mental disorder, physical disability, intellectual disability).
  • (6) Normal cognitive function, no dyslexia; Be able to actively cooperate and participate in investigation and research.

研究者

发起方
Guangdong Provincial Hospital of Traditional Chinese Medicine

相似试验